Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study

Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study

OBJECTIVE: To evaluate the effectiveness and safety of first-generation protease inhibitors for the treatment of genotype 1 hepatitis C virus-infected patients at Brazilian reference centers. METHODS: This multicenter cross-sectional study included hepatitis C virus genotype 1 monoinfected patients...

Full description

Bibliographic Details
Main Authors: Luciana Azevedo Callefi, Cristiane Alves Villela-Nogueira, Simone de Barros Tenore, Dimas Carnaúba-Júnior, Henrique Sérgio Moraes Coelho, Paulo de Tarso A. Pinto, Letícia Cancella Nabuco, Mário Guimarães Pessoa, Maria Lucia Cardoso Gomes Ferraz, Paulo Roberto Abrão Ferreira, Ana de Lourdes Candolo Martinelli, Silvana Gama Florencio Chachá, Adalgisa de Souza Paiva Ferreira, Alessandra Porto de Macedo Bisio, Carlos Eduardo Brandão-Mello, Mário Reis Álvares-Da-Silva, Tânia Reuter, Claudia Alexandra Pontes Ivantes, Renata de Mello Perez, Maria Cássia Jacintho Mendes-Correa
Format: Article
Language:English
Published: Elsevier España
Series:Clinics
Subjects:
Protease inhibitors
Safety
Hepatitis C
Chronic
Therapeutics
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322017000600378&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322017000600378&lng=en&tlng=en

Similar Items